In this week’s View, Dr. Eagle discusses insights from the DAPA-HF Trial concerning the initial decline in Estimated Glomerular Filtration Rate following the initiation of dapagliflozin in patients with heart failure and reduced ejection fraction, then looks at which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation. Finally, Dr. Eagle explores the use of high-intensity statin use among patients with atherosclerosis in the U.S.